The phrase "address infections" is correct and usable in written English.
You can use it when discussing the need to deal with or manage infections, particularly in medical or health-related contexts.
Example: "The healthcare team worked tirelessly to address infections in the hospital to ensure patient safety."
Alternatives: "tackle infections" or "manage infections".
In order to meet the challenges of our current medical need to address infections caused by highly resistant pathogens, we propose the use of superiority trial designs.
Colistin, a polymyxin antibiotic, was chosen specifically to address infections with Acinetobacter species, the most common pathogen associated with combat-related traumatic craniofacial injuries.
To address infections across international borders, countries should prioritize the development and growth of regional and cross-border initiatives.
Inspections sometimes found hospitals failing to address infection control and prevention.
In the fourth example, HFE is used to address infection-control problems in the operating room (OR).
We discuss the first category; categories 2 and 3 are addressed in part 2. We do not address infection control measures for patient care or risk communication.
PLRP enriched in growth factors and antimicrobial proteins has been used to address infection concerns in healing injuries associated with soft tissue defects.
Because of insufficient oversight for the outpatient setting, professional organizations, state medical boards, and federal and state authorities should consider the need to systematically address infection control standards and monitoring tailored for this setting.
Our findings address infection among college students, particularly scholarship athletes, and support a recommendation that student health clinicians and team physicians consider coccidioidomycosis as a possible etiology of illness in students who live in or have traveled recently to disease-endemic regions.
The fourth part addresses infections of a more global perspective such as tuberculosis, HIV, and influenza, and the final part is devoted to emerging and re-emerging infections.
In this review, we examine recent advances in segmental bone defect animal models, bone tissue engineering, and drug delivery with the goal of identifying promising approaches and areas needing further investigation towards developing both a better understanding of and new tissue engineering approaches for addressing infection control while simultaneously initiating bone regeneration.
